亚太地区医用塑料市场预测至 2027 年 - COVID-19 影响和按类型(标准塑料、工程塑料、高性能塑料 (HPP)、硅胶等)和应用(医用一次性用品、假肢、医疗器械和工具、药物输送等)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 127    |    Report Code: TIPRE00017344    |    Category: Chemicals and Materials

Asia Pacific Medical Plastic Market

亚太地区医用塑料研发

2027年亚太地区医用塑料市场预测 - COVID-19 影响和亚太地区 (APAC) 分析 –按类型(标准塑料、工程塑料、高性能塑料 (HPP)、硅胶等);应用(医疗一次性用品、假肢、医疗器械和工具、药物输送等)和国家/地区

页数:127 页

市场介绍

医用塑料由大量高分子材料制成,用于生产医疗保健行业中一致且安全的仪器。它们非常耐用、柔软且经济。这些工具的性能、无菌性和质量是市场扩张的主要因素。医用塑料在诊断仪器、植入物、一次性用品、药物输送装置、手术器械、注射器和导管方面有着广泛的应用。预计全球人口在未来几年将会增加。随着人口的增加,疾病和感染通过多种媒介疯狂传播。老年人口的增加进一步促进了医疗保健行业的发展。此外,医用塑料还用于假肢,它为身体残疾的人提供了改变生活的解决方案。

市场概况和动态

关键细分市场

就类型而言,标准塑料细分市场在2019年亚太医用塑料市场中占据最大市场份额。在应用方面,到2027年,医疗应用和工具细分市场将在医用塑料市场中占据最大市场份额。

主要来源和上市公司

报告中包含亚太医疗塑料市场的一些主要一手和二手来源是塞拉尼斯公司、伊士曼化学公司、GW Plastics、Orthoplasty Limited、Aran Biomedical、Rochling、SABIC、Saint-Gobain、Solvay 和 Dow。

COVID-19大流行对医用塑料市场的影响

COVID-19预计将造成超过3%的损失亚太地区10亿。后果和影响可能会更严重,完全取决于病毒的传播。亚太地区政府正在采取可能的措施,通过宣布封锁来减少其影响,从而影响市场产生的收入。国际机场理事会 (ACI) 亚太区警告称,新冠肺炎 (COVID-19) 疫情的持续时间延长将对该地区机场的运营产生严重影响。连通性和经济可持续性,严重限制它们实现先前预测的增长前景。预计此类关闭将对未来一段时间的市场增长产生负面影响。到目前为止,中国的 COVID-19 确诊病例数最多

购买报告的理由

  • 了解医学塑料市场格局并确定最有可能保证丰厚回报的细分市场
  • 通过了解医疗塑料市场不断变化的竞争格局来保持领先地位
  • 通过确定最有希望销售的细分市场,有效规划医疗塑料市场的并购和合作交易
  • 利用知识丰富的知识通过对医用塑料市场各个细分市场表现的敏锐和全面的分析来做出业务决策
  • 获得2018年至2027年各个细分市场的市场收入预测

亚太地区医用塑料市场细分

按类型

  • 标准塑料
  • 工程塑料
  • 高性能塑料(HPP)
  • 硅胶
  • 其他

按应用

  • 医疗一次性用品
  • 假肢
  • 医疗器械和工具
  • 药物输送
  • 其他

按国家

  • 中国
  • 印度
  • 澳大利亚
  • 日本
  • 韩国
  • 亚太地区其他地区

公司简介< /strong>

  • 塞拉尼斯公司
  • 伊士曼化学公司
  • GW Plastics
  • Ortho Plastics Limited
  • 阿兰生物医学
  • 罗赫林
  • SABIC
  • 圣戈班
  • 索尔维
  • 陶氏化学

 

< p> 

 

 

Asia Pacific Medical Plastic Strategic Insights

Strategic insights for Asia Pacific Medical Plastic involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-medical-plastic-market-strategic-framework.webp
Get more information on this report

Asia Pacific Medical Plastic Report Scope

Report Attribute Details
Market size in 2019 US$ 4,745.4 Million
Market Size by 2027 US$ 9,023.3 Million
Global CAGR (2019 - 2027) 8.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 类型
  • 标准塑料
  • 工程塑料
  • 高性能塑料
  • 硅胶
By 应用
  • 医疗耗材
  • 假肢
  • 医疗器械和工具
  • 药物输送
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Celanese Corporation
  • Eastman chemical company
  • GW Plastics
  • Orthoplastics Limited
  • Aran Biomedical
  • Rochling
  • SABIC
  • Saint-Gobain
  • Solvay
  • Dow
  • Get more information on this report

    Asia Pacific Medical Plastic Regional Insights

    The regional scope of Asia Pacific Medical Plastic refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-medical-plastic-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Medical Plastic Market

    Company Profiles

    1. Celanese Corporation
    2. Eastman chemical company
    3. GW Plastics
    4. Orthoplastics Limited
    5. Aran Biomedical
    6. Rochling
    7. SABIC
    8. Saint-Gobain
    9. Solvay
    10. Dow

     

     

    Frequently Asked Questions
    How big is the Asia Pacific Medical Plastic Market?

    The Asia Pacific Medical Plastic Market is valued at US$ 4,745.4 Million in 2019, it is projected to reach US$ 9,023.3 Million by 2027.

    What is the CAGR for Asia Pacific Medical Plastic Market by (2019 - 2027)?

    As per our report Asia Pacific Medical Plastic Market, the market size is valued at US$ 4,745.4 Million in 2019, projecting it to reach US$ 9,023.3 Million by 2027. This translates to a CAGR of approximately 8.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Medical Plastic Market report typically cover these key segments-

  • 类型 (标准塑料, 工程塑料, 高性能塑料, 硅胶)
  • 应用 (医疗耗材, 假肢, 医疗器械和工具, 药物输送)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Medical Plastic Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Plastic Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Medical Plastic Market?

    The Asia Pacific Medical Plastic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Celanese Corporation
  • Eastman chemical company
  • GW Plastics
  • Orthoplastics Limited
  • Aran Biomedical
  • Rochling
  • SABIC
  • Saint-Gobain
  • Solvay
  • Dow
  • Who should buy this report?

    The Asia Pacific Medical Plastic Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Plastic Market value chain can benefit from the information contained in a comprehensive market report.